Additional enhancements included the attachment of an epidermal growth factor (EGF) peptide, which improved BBB penetration, resulting in higher and faster accumulation of these agents, specifically in brain tumor regions [71, 93, 94, 106]. The gene discussed is EGF; the disease is brain neoplasm.